DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Somavert (Pegvisomant) - Current Clinical Trials


Somavert Related Clinical Trials

Pegvisomant With Glucagon Test to Assess for Adult Growth Hormone Deficiency [Recruiting]

Acute Application of Pegvisomant and Octreotide in Acromegaly [Completed]

Safety, Tolerability and Relative Bioavailability of Pegvisomant in Healthy Subjects [Completed]

Tissue Biomarker for Pegvisomant Action [Completed]

Change in Quality of Life After Addition of Weekly 40 mg Pegvisomant/Placebo in Controlled Acromegalic Patients [Completed]

Acromegaly Combination Treatment Study [Recruiting]

Co-treatment With Pegvisomant and a Somatostatin Analogue (SA) in SA-responsive Acromegalic Patients [Completed]

Figitumumab Combined With Pegvisomant For Advanced Solid Tumors [Terminated]

Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant [Recruiting]

Non Interventional Study For Patients Treated With Somavert® [Completed]

Long Term Use of Pegvisomant For A Regulatory Post Marketing Commitment Plan [Active, not recruiting]

Role of Growth Hormone Antagonism in Modulating Insulin Sensitivity in Subjects With Pre-diabetes [Active, not recruiting]

Canadian Pegvisomant Compassionate Study In Acromegalic Patients [Completed]

Pegvisomant And Sandostatin LAR Combination Study [Completed]

Study to Evaluate the Efficacy and Safety of Sandostatin LAR at High Dose or in Combination Either With GH-receptor Antagonist or Dopamine-agonist in Acromegalic Patients [Completed]

Long Term Study With B2036-PEG [Completed]

Lanreotide Autogel and Pegvisomant Combination Therapy in Acromegalic Patients [Completed]

Effect of Pegvisomant on GH/IGF-I Relationship in GHD [Terminated]

A Relative Bioavailability Study To Evaluate Safety, Tolerability And Pharmacokinetic Comparability Of Pegvisomant 1 X 30 Mg Vs 2 X 15 Mg Subcutaneously Administered In Healthy Subjects [Completed]

A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome [Completed]

A Study To Compare The Efficacy And Safety Of Pegvisomant To That Of Sandostatin Lar Depot In Patients With Acromegaly [Completed]

Effect of DPP4 Inhibition on Growth Hormone Secretion [Recruiting]

Growth Hormone Signaling in Vivo in Humans [Completed]

Growth Hormone, IGF-1 and Medical Treatment in Acromegaly: Are There Effects on Gut Hormone Physiology and Postprandial Substrate Metabolism? [Recruiting]

The Relationship Between the Growth Hormone (GH)- Insulin Like Growth Factor I (IGF-I) System and the Inflammatory System in Healthy Normal Persons [Enrolling by invitation]

Substrate Metabolism, Growth Hormone Signaling, and Insulin Sensitivity During Fasting [Recruiting]

Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly [Completed]

Growth Hormone During Fasting.Signaltransduktion in Muscle and Adipose Tissue and Changes in Intrahepatic Lipid Content [Completed]

Acromegaly Treatment Quality of Life Study [Recruiting]

Cardiac Function and Morphology Evaluated by Magnetic Resonance Imaging in Growth Hormone Deficiency and Acromegaly [Completed]

Assessment of Changes in Metabolic Activity in Liver & Skeletal Muscle in Patients Suffering From Acromegaly [Recruiting]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017